4.5 Article

Effect of taurine-conjugated ursodeoxycholic acid on endoplasmic reticulum stress and apoptosis induced by advanced glycation end products in cultured mouse podocytes

Journal

AMERICAN JOURNAL OF NEPHROLOGY
Volume 28, Issue 6, Pages 1014-1022

Publisher

KARGER
DOI: 10.1159/000148209

Keywords

diabetic nephropathy; advanced glycation end products; apoptosis; endoplasmic reticulum stress; podocyte; taurine-conjugated ursodeoxycholic acid

Ask authors/readers for more resources

Background: Activations of death receptors and mitochondrial damage are well-described common apoptotic pathways. Recently, a novel pathway via endoplasmic reticulum (ER) stress has been reported. Methods: We assessed the role of tauroursodeoxycholic acid (TUDCA) in inhibition of ER stress and its protective effect on advanced glycation end products (AGEs)-induced apoptosis in murine podocytes. Podocytes were incubated with increasing doses of AGEs for variable time periods. Apoptosis was quantitatively determined by flow cytometry detecting propidium iodide expression and annexin V binding simultaneously. Level of glucose-regulated protein 78 (ER stress marker) expression was determined by Western blot. Intracellular calcium concentration ([Ca2+](i)) was recorded by a laser confocal microscope and the Ca2+ indicator Fluo-3 labeling. Results: AGEs induced podocyte apoptosis and increased the expression of glucose-regulated protein 78 in a dose-and time-dependent manner as compared with bovine serum albumin. These changes were accompanied by a rapid rise in [Ca2+](i) of podocytes. TUDCA was capable of abolishing AGEs-induced expression of glucose-regulated protein 78 and subsequently inhibited apoptosis in a dose-dependent manner. Conclusion: We propose that ER stress plays an important role in AGEs-induced apoptosis and that TUDCA prevents apoptosis by blocking an ER stress-mediated apoptotic pathway. This novel mechanism of TUDCA action suggests new intervention methods for AGEs-induced apoptosis of mouse podocytes in diabetic nephropathy. Copyright (C) 2008 S. Karger AG, Basel.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available